ACA
BNTX icon

Atlas Capital Advisors’s BioNTech BNTX Stock Holding History

Atlas Capital Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$5.64K Hold
53
– – ﹤0.01% 810
2025
Q1 		$4.83K Hold
53
– – ﹤0.01% 852
2024
Q4 		$6.04K Hold
53
– – ﹤0.01% 816
2024
Q3 		$6.29K Hold
53
– – ﹤0.01% 760
2024
Q2 		$4.26K Hold
53
– – ﹤0.01% 788
2024
Q1 		$4.89K Hold
53
– – ﹤0.01% 767
2023
Q4 		$5.59K Hold
53
– – ﹤0.01% 786
2023
Q3 		$5.76K Hold
53
– – ﹤0.01% 757
2023
Q2 		$5.72K Hold
53
– – ﹤0.01% 777
2023
Q1 		$6.6K Sell
53
-1,487
-97% -$204K ﹤0.01% 775
2022
Q4 		$231K Buy
+1,540
New +$237K 0.04% 319

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Atlas Capital Advisors's BNTX Position: Q2 2025 in Review

Atlas Capital Advisors held its BioNTech (BNTX) position steady in Q2 2025 at 53 shares worth $5.64K. The position accounts for ﹤0.01% of the portfolio, ranked #810.

Atlas Capital Advisors first reported a position in BNTX in Q4 2022 and has held it in 11 quarters since. The position peaked at $231K in Q4 2022. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Atlas Capital Advisors held 53 shares of BioNTech worth $5.64K as of Q2 2025.
  • Atlas Capital Advisors left its BioNTech share count unchanged in Q2 2025.
  • BioNTech made up ﹤0.01% of Atlas Capital Advisors's portfolio in Q2 2025, its #810 holding.
  • Atlas Capital Advisors first reported a position in BioNTech in Q4 2022 and has held it in 11 quarters since.
  • Atlas Capital Advisors's BioNTech position peaked at $231K in Q4 2022.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Atlas Capital Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.